Clinical Trials Logo

Filter by:
NCT ID: NCT02699177 Not yet recruiting - Clinical trials for Primary Ciliary Dyskinesia

In Vivo Measurements of Nasal Ciliary Beat Frequency by Using Interferometry

Start date: April 2016
Phase: N/A
Study type: Observational

1. Assessment of a high speed video camera with a green light source for the measurement of ciliary beat frequency (CBF) in the nasal airways of patients. 2. Assessments of the effect of drugs and other therapies on CBF using the study system. 3. Comparison of results with standard methods such as ciliary brush biopsies

NCT ID: NCT02702349 Not yet recruiting - Penicillin Allergy Clinical Trials

The Frequency of Positive Challenge Test to Penicillin in Children Suspected to Have Allergy to Penicillin

Start date: April 2016
Phase: N/A
Study type: Interventional

The incidence of reactions during penicillin challenge tests among children with suspected penicillin allergy

NCT ID: NCT02704013 Not yet recruiting - Overactive Bladder Clinical Trials

Urinary Biomarkers in Overactive Bladder in Children

Start date: April 2016
Phase: N/A
Study type: Interventional

It is a single-center, prospective, interventional, single-arm study. Aim is to investigate which variables are significantly correlated with prolonged anticholinergic treatment (>6 months) in children with overactive bladder (OAB). Investigated variables will include urinary neurotrophins and inflammatory cytokines, sonographic biomarkers, symptom score scale, demographics, and urodynamic findings. Secondary aim is to analyze sensitivity and specificity of urinary biomarkers in diagnosis and management of OAB compared to urodynamics and treatment outcome.

NCT ID: NCT02704338 Not yet recruiting - Autoimmune Diseases Clinical Trials

Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis

Treg
Start date: April 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Separated and expanded the CD4+CD25+CD127- Tregs from peripheral blood of autoimmune hepatitis patients and administrate the cells (5 x 106 cells/kg) into patients.

NCT ID: NCT02704546 Not yet recruiting - Methylphenidate Clinical Trials

Methylphenidate (Ritalin®) Effect During Exposure to Exercise and Heat Stress in ADD/ADHD Treated Patients

Start date: April 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the possible effects of MPH use on physiological functions among ADHD\ADD patients, by performing a set of physical trials to assess aerobic and anaerobic capacity, to characterize the tendency for muscle break down while performing monitored moderate physical effort and to assess the physiological strain while performing moderate exercise in heat load conditions by using the heat tolerance test.

NCT ID: NCT02704806 Not yet recruiting - Clinical trials for Immunol Feature in Circulation and Thromb in AMI Patients

Immunologic Analysis of Peripheral Blood and Aspirated Thromb In AMI Patients

ATAIA
Start date: April 2016
Phase: N/A
Study type: Observational

Researchers use FCM to analyze the immunol cell feature and its corresponding activation status, as well as the thromb aspirated through the thromb aspiration device in AMI patients

NCT ID: NCT02705131 Not yet recruiting - Clinical trials for Cervical Radiculopathy

Balance Chiropractic Therapy for Cervical Spondylotic Radiculopathy

Start date: April 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the therapeutic effect and safety of the Balance Chiropractic Therapy(BCT) on Cervical Spondylotic Radiculopathy and to investigate the mechanism of which this efficacy is achieved.

NCT ID: NCT02706158 Not yet recruiting - Pre-eclampsia Clinical Trials

Dietary Intervention Program for Pre-eclampsia in Women at Risk

Start date: April 2016
Phase: N/A
Study type: Interventional

Aims: Pre-eclampsia is one of the leading causes of maternal and perinatal morbidity and mortality worldwide. Preeclampsia frequency is 2-8% from all pregnancies. Dietary factors and dietary status have been suggested to play a role in development of preeclampsia. Low intake of nutrients such as calcium, vitamin D, magnesium, omega 3 fatty acids, is related to increased risk of preeclampsia. Also high triglyceride levels, high BMI, low Omega 6: omega 3 ratio and high calories consumption are possible risk factors. Material and Methods: A prospective study will be carried out. Woman medically diagnosed as high risk for preeclampsia will randomly be assigned to dietary treatment or no dietary treatment groups. In the dietary treatment group, besides medical care, all woman will get calcium and vitamin D supplementation from 8th to 16th gestational weeks, and thereafter until delivery personal extensive nutritional guidance. A 3 day food diary will be collected at inclusion and thereafter at Gestational weeks 16 and 28. All routinely collected data during pregnancy (blood tests, weight, blood pressure and preeclampsia symptoms) will be documented. In both groups incidence of pre-eclampsia and eclampsia, blood pressure and protein in urine will be recorded.

NCT ID: NCT02709304 Not yet recruiting - Clinical trials for Urinary Catheter Discomfort in Surgical Patients

Efficacy of Lidocaine Gel in Reducing Foley Catheter Discomfort in Surgical Patients

Start date: April 2016
Phase: Phase 4
Study type: Interventional

This study will evaluate whether lidocaine gel for urinary catheter insertion would decrease pain and discomfort associate with Foley catheters upon awakening from general anesthesia in the post anesthesia care unit. As a secondary objective, the study will evaluate bacterial colony counts from urine obtained from the surgical patients after insertion of the Foley catheter prior to prophylactic antimicrobial administration.

NCT ID: NCT02710539 Not yet recruiting - Clinical trials for Arterial Hypertension

Once-daily Fixed Combination of Three Antihypertensive Drugs

ONE&ONLY
Start date: April 2016
Phase: Phase 4
Study type: Interventional

Randomized comparison of once-daily fixed combiNation versus free-drug combination of three antihypertensive agents in arterial hypertension